59
Participants
Start Date
January 27, 2022
Primary Completion Date
July 24, 2023
Study Completion Date
July 24, 2023
Integrated Intervention for Breast Cancer Survivors with Diabetes
"All pilot participants will be required to have a SMB target to be included in this study. A SMB target will be chosen by the participant after reviewing their 18mo follow-up responses with the Care Coach. Participants may endorse a maladaptive belief or emotional response; however, this is not required to participate in this intervention. At each follow-up session, the Care Coach will review the participant's SMB goal and progress, address participant's challenges and suggest alternatives, and correct further misinformation on the disease(s). Additionally, the Care Coach will reinforce or introduce techniques that could help overcome barriers to reaching SMB goal and recommend participants to continue improving on the same goal or begin action planning towards a new SMB goal.~1. Just SMB concern~2. SMB + maladaptive belief + emotional response~3. SMB + maladaptive belief~4. SMB + emotional response"
Attention Control
Participants in the control arm will receive a brochure to discuss healthy lifestyle behaviors to improve DM management. To control for the potentially confounding effect of personalized attention from the care coach on the relationship between the intervention and outcomes, participants also receive 4 calls to discuss study progress, thoughts and feelings about study/illness/behaviors, remind them about returning their pill bottles, and about scheduling for their upcoming 24mo follow-up study interview.
Icahn School of Medicine at Mount Sinai, New York
Northwell Health, New Hyde Park
Feinberg School of Medicine, Chicago
Collaborators (1)
Northwestern University Feinberg School of Medicine
OTHER
Feinstein Institute for Medical Research
OTHER
National Cancer Institute (NCI)
NIH
Icahn School of Medicine at Mount Sinai
OTHER